Abstract
In contrast to most of the visceral complications of malignancy, the secondary genitourinary manifestations of cancer are more commonly due to distant effects from the tumor or the therapy rather than from direct involvement of the kidneys with tumor. Tumors rarely metastasize to the kidneys in spite of high blood flow through these paired organs. Tumor involvement of the ureters, however, occurs commonly as a consequence of pelvic or retroperitoneal metastases. Lymphomas and testicular and ovarian tumors involve retroperitoneal nodes, displace the ureters, and occasionally invade the ureteral wall. Prostatic, bladder, and uterine cancers grow by contiguous extension through and along the ureteral wall. The genitourinary complications of malignancy may therefore be manifestations of either primary tumors of the genitourinary tract or secondary metastases from contiguous or distant tumors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Afzal, M. et al. Hypouricemia and proximal renal tubular dysfunction in acute myeloid leukemia. Br. Med. J 5934: 775–777, 1974.
Aptekar, R. Bladder toxicity with chronic oral cyclophosphamide treatment in non-malignant disease. Arthritis Rheum. 16: 361–467, 1973.
Bryan, C. Acute renal failure in multiple myeloma. Am. J. Med 44: 128–133, 1968.
Editorial. Hyperuricemic acute renal failure. Lancet 1266–1267, 22 June 1974.
Frei, E., Ill et al: Renal complications of neoplastic disease. J. Chronic Dis 16: 757–776, 1963.
Ghosh, L. et al. The nephrotic syndrome: a prodome to lymphoma. Ann. Intern. Med 72: 379–382, 1970.
Kaplan, B. S. Glomerular injury in patients with neoplasia. Annu. Rev. Med 27: 117–125, 1976.
Lee,J. C. The association of cancer and the nephrotic syndrome. Ann. Intern. Med 64: 41–51, 1968.
Liu, K. et al. Renal toxicity in man treated with mitomycin C. Cancer 28: 1314–1320, 1971.
Loughridge, L. Nephrotic syndrome in malignant disease of nonrenal origin. Lancet 1: 256–259, 1971.
Luxton, R. W. Radiation nephritis. Q. J. Med 22: 215–242, 1953.
McCurdy, D. M. et al. Renal tubular acidosis due to amphoteracin B.N. Engl. J. Med. 278: 124–131, 1968.
Mir, M. A. et al. Hypokalemia in acute myeloid leukemia. Ann. Intern. Med 82: 54–57, 1975.
Myerowitz, R. L. et al. Nephrotoxic and cytoproliferative effects of streptozotocin. Cancer 38: 1550–1555, 1976.
Pitman, S. et al. The pathogenesis of methotrexate nephropathy. Clin. Res 24: 380A, 1976.
Plager, J. E. Association of renal injury with combined cephalothin-gentamicin therapy among patients severely ill with malignant disease. Cancer 37: 1937–1943, 1976.
Richmond, J. et al. Renal lesions associated with malignant lymphoma. Am. J. Med 32: 184–207, 1962.
Routledge, R. C. et al. Hodgkin’s disease complicated by the nephrotic syndrome. Cancer 38: 1735–1740, 1976.
Sadoff, L. Nephrotoxicity of streptozotocin (NCS-85998). CCR 54: 457–459, 1970.
Shrom, S. H. Formalin treatment for in-tractable hemorrhagic cystitis: a literature review. Cancer 38: 1785–1789, 1976.
Talley, R. W. et al. Clinical evaluation of toxic effects of CPDD—phase I clinical study. CCR 57: 465–471, 1973.
Zlotnick, A. Renal pathologic findings associated with monoclonal gammopathies. Arch. Intern. Med 135: 40–45, 1975.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 G.K. Hall & Co.
About this chapter
Cite this chapter
Lokich, J. (1980). Renal Complications of Malignancy. In: Lokich, J.J. (eds) Clinical Cancer Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7235-6_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-7235-6_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7237-0
Online ISBN: 978-94-011-7235-6
eBook Packages: Springer Book Archive